Scaling LCA in pharma: from PAS2090 compliance to portfolio‑level insight
Innovation Pitch
2026-05-28 | 12:00 PM - 12:30 PM | The Innovation Corner
Abstract
Pharmaceutical companies face rising pressure to provide consistent, comparable sustainability data across their products and obtain input from suppliers. Ramboll’s Director of LCA, Sam Hinton, will outline how organisations can move beyond single‑product LCAs to build scalable, decision‑ready sustainability intelligence.
The session explores how to meet different reporting standards such as PAS2090; scale LCA to report against multiple SKUs and production sites; and embed insights into product development and portfolio‑level decisions. The emphasis is on converting LCA data into actionable intelligence that identifies impacts, improvement opportunities, and strategic priorities.
The presentation will also cover robust monitoring, reporting and verification (MRV) that is needed to ensure emission‑reduction claims are consistently tracked and verified across the value chain.
What to expect?
- Understand key distinctions between PAS2090 and other applicable standards
- Practical approaches for scaling sustainability reporting across SKUs, suppliers and production locations including API‑enabled data flows
- Learn how Portfolio Sustainability Assessments consolidate insights to enable decision makers
